QLI: רווח נקי למניה (EPS TTM) Qilian International

The GURU.Markets summary chart of 12-month EPS dynamics, where the current mark equals -0.22, is based on the success of the Chinese organic components and heparin ecosystem. Qilian International (QLI) strives for leadership in the veterinary and chemical reagents segment by modernizing the traditional approach. Stability is ensured by pharmaceutical substance plants with regular updates to extraction equipment.

The risk of asset overvaluation at Qilian International (QLI) requires strict control via fundamental metrics. For a pharmaceutical business based on traditional Chinese medicine, the efficiency of scaling capacity is critical. The EPS TTM history demonstrates net profit adjusted for capital dilution over the last 12 months. The current value of -0.22 reflects the real yield per share. An analysis of the chart's extremes allows for a distinction between sustainable demand growth and temporary market euphoria.